Andres Gomez, Associate Professor at The Autonomous University of Nuevo León, shared a post on X/Twitter:
“40 mg of nivolumab is enough for treating Hodgkin Lymphoma, plus or minus chemotherapy. Learn about resource optimization in Low- and Middle-Income Countries with Héctor Vaquera.”
Source: Andres Gomez/X